Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Piazza

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Medicinal Chemistry|October 20, 2009
Discovery of colon tumor cell growth inhibitory agents through a combinatorial approachAshraf H Abadi, Dalal A Abouel-Ella, Jochen Lehmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 1, 2018
Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agentsWagdy M Eldehna, Reem I Al-Wabli, Maha S Almutairi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 30, 2010
Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibitionHeather N Tinsley, Bernard D Gary, Jose Thaiparambil, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 26, 2012
Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agentsMohamed A O Abdel-Fattah, Mahmoud A M El-Naggar, Rasha M H Rashied, et al.
Oncotarget|March 7, 2015
Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiationKaushlendra Tripathi, Usama K Hussein, Roja Anupalli, et al.
Molecular Cancer Therapeutics|February 28, 2013
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyEvrim Gurpinar, William E Grizzle, John J Shacka, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|August 26, 2016
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemopreventionTarek Aboul-Fadl, Suliman S Al-Hamad, Kevin Lee, et al.
Archiv Der Pharmazie|April 16, 2018
Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitorsLina Y El-Sharkawy, Rowaida A El-Sakhawy, Mohammad Abdel-Halim, et al.
Plos One|June 5, 2014
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancerRitu Arora, Clayton Yates, Bernard D Gary, et al.
Biochemical and Biophysical Research Communications|December 19, 2015
Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancerRanganatha R Somasagara, Kaushlendra Tripathi, Sebastian M Spencer, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Medicinal Chemistry|October 20, 2009
Discovery of colon tumor cell growth inhibitory agents through a combinatorial approachAshraf H Abadi, Dalal A Abouel-Ella, Jochen Lehmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 1, 2018
Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agentsWagdy M Eldehna, Reem I Al-Wabli, Maha S Almutairi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 30, 2010
Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibitionHeather N Tinsley, Bernard D Gary, Jose Thaiparambil, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 26, 2012
Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agentsMohamed A O Abdel-Fattah, Mahmoud A M El-Naggar, Rasha M H Rashied, et al.
Oncotarget|March 7, 2015
Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiationKaushlendra Tripathi, Usama K Hussein, Roja Anupalli, et al.
Molecular Cancer Therapeutics|February 28, 2013
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyEvrim Gurpinar, William E Grizzle, John J Shacka, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|August 26, 2016
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemopreventionTarek Aboul-Fadl, Suliman S Al-Hamad, Kevin Lee, et al.
Archiv Der Pharmazie|April 16, 2018
Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitorsLina Y El-Sharkawy, Rowaida A El-Sakhawy, Mohammad Abdel-Halim, et al.
Plos One|June 5, 2014
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancerRitu Arora, Clayton Yates, Bernard D Gary, et al.
Biochemical and Biophysical Research Communications|December 19, 2015
Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancerRanganatha R Somasagara, Kaushlendra Tripathi, Sebastian M Spencer, et al.
Pageof 12